Purchase Order 75N95C25P00097
Award Date 9/16/25
Potential Completion Date 9/15/26
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $29,376 firm-fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Reaction Biology Corporation, a self-certified small disadvantaged business. The award is to obtain kinase hotspot assay compound testing services from Reaction Biology. This contract is not associated with a larger vehicle. The purpose is to test 120 novel small molecule compounds for inhibitory activity...
- The National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health, awarded a $59.8K firm fixed-price purchase order to Reaction Biology Corporation for bioactive small molecule development services. The contract, awarded on September 19, 2025, with an ultimate completion date of September 22, 2026, encompasses Gamma 33P ATP kinase assay and NanoBRET kinase assay services to be performed at the contractor's facility in Malvern, Pennsylvania. This...
- The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm-fixed-price purchase order contract worth $18,028.80 to Reaction Biology Corporation, a self-certified small disadvantaged business. The contract, which does not have a set-aside designation, was awarded on June 5, 2019, with a completion date of December 13, 2019. Reaction Biology Corporation, a drug discovery contract research organization,...
- This is a $19,840.00 firm-fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Reaction Biology Corporation, a self-certified small disadvantaged business. The contract is for biochemical kinase assays on 160 compounds to determine their inhibitory activity against the kinases LATS1, LATS2, and AKT, which will inform the development of potential anti-cancer agents. This award was a...
- This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to BPS Bioscience Inc., a for-profit Subchapter S Corporation that produces high-quality enzymes, assay kits, and other biological reagents for biomedical research. The $22,600.00 purchase order contract has a firm fixed price and a completion date of August 31, 2019. The award was not set aside for any particular business type. BPS...
- The National Institute on Drug Abuse (NIDA), on behalf of the National Center for Advancing Translational Sciences (NCATS), awarded a $99,000 firm fixed-price purchase order to Life Technologies Corporation, doing business as Thermo Fisher Scientific, to independently provide services to obtain kinases' percent inhibition for 5,000 data points at one concentration and 400 IC50 curves of malaria compounds. This non-competitive acquisition leverages Life Technologies' specialized expertise in...
- Promega Corporation received a firm fixed price contract award valued at $9,344.70 from the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health, for the procurement of ADP-Glo Kinase Assay kits containing 10,000 assays. The contract was awarded on August 20, 2015, with an ultimate completion date of February 29, 2016, and was executed as a call against Promega's existing $10 million Blanket Purchase Agreement with the NIH Office of...
- This $125,600.00 firm fixed-price purchase order was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Reaction Biology Corporation, a self-certified small disadvantaged business, to conduct testing of novel small molecule compounds for kinase inhibition. The contract does not have a set-aside designation. The work involves screening 300 compounds against 3 wild-type kinases and 10 compounds against a panel of 50 wild-type kinases using...
- Government Scientific Source Inc., a small business located in Reston, Virginia, was awarded a $275,486.19 firm fixed-price Blanket Purchase Agreement (BPA) call by the National Center for Advancing Translational Sciences (NCATS) on June 3, 2015, with a completion date of June 30, 2015. The contract covers the procurement of an IQUE Screener HD 110V, a specialized laboratory instrument used for high-throughput cell analysis and screening applications. This award was issued under the General...
- This federal contract award provides NCATS (National Center for Advancing Translational Sciences) with testing services for 100 small molecule compounds, including CYP (cytochrome P450) inhibition testing. The $152,000.06 fixed-price purchase order was awarded to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The contract work is not set aside for small businesses. Cyprotex specializes in predictive toxicology, ADME (absorption, distribution, metabolism, and...